small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (385)
  • Capabilities (83)
  • Experience (288)
  • Insights & News (2,801)
  • Other Results (83)

Professionals 385 results

David A. Sakowitz
David A. Sakowitz
Partner
  • New York, 
  • London
Email
+1 212-294-2639
vCard

Partner

  • New York
  • London
Michael J. Blankenship
Michael J. Blankenship
Partner
  • Houston, 
  • San Francisco , 
  • New York
Email
+1 713-651-2678
vCard

Partner

  • Houston
  • San Francisco
  • New York
Louis Savage
Louis Savage
Partner
  • Houston
Email
+1 713-651-2797
vCard

Partner

  • Houston
View All Professionals

Capabilities 83 results

Practice Area

Capital Markets

Our capital markets and securities attorneys represent U.S. and international issuers, institutional investors, underwriters, and placement agents in a wide variety of public and private offerings of debt and equity securities....Read more

Practice Area

Private Equity

Winston & Strawn’s private equity attorneys provide strategic advice and legal counsel to middle-market private equity funds, hedge funds, family offices, real estate funds, alternative asset managers, portfolio companies, and institutional investors. We have one of the broadest and most active national middle-market private equity practices in the U.S. ...Read more

Practice Area

Structured Finance

Our structured finance group is widely recognized as a leader, encompassing Esoteric Finance, Residential Asset Finance and Securitization, and CLOs/Fund Finance. Positioned prominently at the forefront of the industry, our team boasts extensive experience across a broad spectrum of assets, with a particular focus on bespoke structures and emerging and/or “esoteric” assets, including residential and commercial PACE, RMBS, and CMBS; aircraft, vessel, and railcar finance; FinTech and marketplace lending; CLOs; specialty finance; consumer and business lending; energy structured finance (including solar finance and reserve-based finance); derivatives and structured products; lease and operating asset finance; trade receivables; litigation settlement financing; and life settlements....Read more

Experience 288 results

Experience

|

February 22, 2026

Winston advised the Compagnie Européenne de Garantie et Caution (CEGC, BPCE Group) financial creditors on the adoption of Réalités’ recovery plan by the Nantes Commercial Court

Winston & Strawn LLP Paris advised the Compagnie Européenne de Garantie et Caution (CEGC, BPCE Group) financial creditors on the adoption of Réalités’ recovery plan by the Nantes Commercial Court....Read more

Experience

|

February 18, 2026

RF Acquisition Corp III Announces Closing of $100 Million Initial Public Offering

Winston & Strawn LLP represented  RF Acquisition Corp III, a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, in connection with its $100M initial public offering. The Company priced 10,000,000 units at a price of $10.00 per unit. The units are listed on the Nasdaq Global Market and began trading under the ticker symbol “RFAMU” on February 13, 2026. Each unit consists of one ordinary share, par value $0.0001 per share, and one right to receive one-tenth of one ordinary share. ...Read more

Experience

|

February 6, 2026

Winston Represented ETi Gida in Acquisition of TRUBAR

A Winston deal team, led by Tim Kincaid, Brad Vaiana and Ben Popeck, represented Turkish snack company ETI Gida Sanayi ve Ticaret Anonim Sirketi (ETi Gida) in its acquisition of Miami-based TRUBAR, a popular nutrition bar known for dessert-inspired flavor and clean ingredients. ...Read more
View All Experience

Insights & News 2,801 results

Sponsorship

|

March 23, 2026

Winston & Strawn Sponsors Healthcare Business International (HBI) 2026

We are proud to be an Elite Sponsor of the 2026 Healthcare Business International Conference in Paris. This must-attend event brings together leading decision-makers from the global for-profit healthcare sector to explore new business opportunities, drive growth, and shape the future of healthcare....Read more

Sponsorship

|

March 22, 2026

Winston & Strawn Sponsors 38th Annual Roth Conference

Winston & Strawn is proud to sponsor the 38th Annual Roth Conference. This year, the program will feature one-on-one and small group meetings, analyst-selected fireside chats, industry keynotes, and panel discussions. ...Read more

Capital Markets & Securities Law Watch

|

March 17, 2026

|

4 Min Read

SEC Staff Provides Relief for Delayed Section 16(a) Reporting Due to EDGAR Access Delays

On March 13, 2026, the staff of the Securities and Exchange Commission (SEC) updated its Holding Foreign Insiders Accountable Act Frequently Asked Questions (FAQs) to provide relief for directors and officers of both foreign private issuers and domestic companies encountering delays with obtaining EDGAR access codes due to the flood of applications received as the March 18, 2026 effective date approaches.

View All Insights & News

Other Results 83 results

Site Content

What Is Emerging Technology?

Emerging technology is a term generally used to describe a new technology, but it may also refer to the continuing development of an existing technology; it can have slightly different meaning when used in different areas, such as media, business, science, or education. The term commonly refers to technologies that are currently developing, or that are expected to be available within the next five to ten years, and is usually reserved for technologies that are creating, or are expected to create, significant social or economic effects....Read more

Law Glossary

What Is Consumer Marketing Law?

Consumer marketing law is a broad legal segment dealing with federal and state statutes, along with government regulations, established to ensure that marketing and advertising are truthful. Federal law states that no form of advertising, including online advertising, can be deceptive. Marketing claims must also be evidence-based....Read more

Law Glossary

What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?

Congress passed the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in 2010 an amendment of the Public Health Services Act. The BPCIA is codified at 42 U.S.C. § 262....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising